Trial Profile
Efficacy and tolerability of mirtazapine in patients with post-myocardial infarction depression in the Myocardial Infarction and Depression-Intervention Trial (MIND-IT)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary) ; Citalopram
- Indications Cardiovascular disorders; Depression
- Focus Therapeutic Use
- Acronyms MIND-IT
- 24 May 2012 New source identifed and integrated (ISRCTN: Current Controlled Trials record.)
- 01 Feb 2011 Substudy results published in the Neuropsychobiology.
- 05 Nov 2010 New trial record.